Cargando…
Tocilizumab, a Proposed Therapy for the Cachexia of Interleukin6-Expressing Lung Cancer
BACKGROUND: We previously reported the role of IL-6 in a murine model of cancer cachexia and currently documented a patient in whom tocilizumab, anti-IL-6 receptor antibody, dramatically improved cachexia induced by IL-6 over-expressing lung cancer. Despite this potential to alleviate cancer cachexi...
Autores principales: | Ando, Katsutoshi, Takahashi, Fumiyuki, Kato, Motoyasu, Kaneko, Norihiro, Doi, Tokuhide, Ohe, Yuichiro, Koizumi, Fumiaki, Nishio, Kazuto, Takahashi, Kazuhisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092149/ https://www.ncbi.nlm.nih.gov/pubmed/25010770 http://dx.doi.org/10.1371/journal.pone.0102436 |
Ejemplares similares
-
Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis
por: Nakashita, Tamao, et al.
Publicado: (2014) -
Associations between peripheral blood eosinophil counts in patients with systemic sclerosis and disease severity
por: Ando, Katsutoshi, et al.
Publicado: (2016) -
Hochuekkito (TJ-41), a Kampo Formula, Ameliorates Cachexia Induced by Colon 26 Adenocarcinoma in Mice
por: Yae, Suzu, et al.
Publicado: (2012) -
TWEAK enhances TGF-β-induced epithelial-mesenchymal transition in human bronchial epithelial cells
por: Itoigawa, Yukinari, et al.
Publicado: (2015) -
Hypoxia Increases Gefitinib-Resistant Lung Cancer Stem Cells through the Activation of Insulin-Like Growth Factor 1 Receptor
por: Murakami, Akiko, et al.
Publicado: (2014)